Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11753640 Oligonucleotides for modulating Tau expression

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

December 31, 2020

Date of Patent

September 12, 2023

Patent Application Number

17139161

Patent Citations

‌

US Patent 8513207 Extended dicer substrate agents and methods for the specific inhibition of gene expression

‌

US Patent 9458153 Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection

‌

US Patent 10093671 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection

‌

US Patent 9683235 Compositions for modulating Tau expression

‌

US Patent 11279929 Oligonucleotides for modulating Tau expression

‌

US Patent 8090542 Functional and hyperfunctional siRNA

‌

US Patent 8349809 Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression

Patent Inventor Names

Peter Hagedorn

Anja Mølhart Høg

Marianne L. Jensen

Richard E. Olson

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11753640

Patent Primary Examiner

CPC Code

Find more entities like US Patent 11753640 Oligonucleotides for modulating Tau expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.